Your session is about to expire
← Back to Search
Topical HO/03/03 for Diabetic Foot Ulcers (Truheal Trial)
Truheal Trial Summary
This trial is testing the safety and efficacy of a topical treatment for diabetic foot ulcers.
Truheal Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTruheal Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Truheal Trial Design
Find a Location
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is it possible to register for participation in this experiment?
"This medical trial requires that those who apply have an existing foot ulcer, and be between 18-80 years old. In total, 196 participants must meet the criteria to make it a viable study."
How many centers are leading the implementation of this experiment?
"At present, St. Vincent Wound Care Center IDI Research in Indianapolis, Indiana, Dr. Ian Gordon in Long Beach, California and North American Centre for Limb Preservation in New Haven, Connecticut are some of the 19 medical centres actively enrolling patients for this investigation."
Is the population of this clinical trial inclusive to those over thirty years old?
"This trial is open to participants aged 18 and over but not exceeding 80 years."
Are participants still being admitted to this research project?
"Per clinicaltrials.gov, this medical trial is not presently recruiting for patient participation. It was initially published on February 1st 2010 and most recently edited three years later in April 2013. However, there are currently 390 other trials that have open enrollment at the time of writing."
Has the FDA sanctioned HO/03/03 10µg?
"Due to the lack of evidence indicating efficacy, our team at Power assigned a score of 2 when judging HO/03/03 10µg's safety profile. This is because it is only in Phase 2 trials and has limited data demonstrating its security."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger